Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
docosahexaenoic acid + arachidonic acid + milk fat globule membrane
- Development stage
- Unknown
- Lead developer
- Arla Foods Ingredients
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
Docosahexaenoic acid (DHA) + arachidonic acid (ARA) + milk fat globule membrane (MFGM) is a specialized nutritional combination primarily utilized in infant formulas to support brain development and immune health. DHA and ARA are long-chain polyunsaturated fatty acids (LCPUFAs) that serve as critical structural components of the brain and retina, influencing synaptic plasticity and visual acuity. MFGM is a complex biological fraction derived from milk that contains a variety of phospholipids, sphingolipids (such as sphingomyelin and gangliosides), and bioactive proteins (including lactadherin and butyrophilin). Clinical studies, notably those conducted by Mead Johnson Nutrition, have demonstrated that the addition of MFGM to formula containing DHA and ARA can improve neurodevelopmental scores and reduce the incidence of common pediatric infections, such as otitis media, by more closely mimicking the composition and functional benefits of human breast milk.
- Brand names
- Enfamil EnspireEnfamil NeuroPro
- Other names
- DHA + ARA + MFGM
02
Targets
PPARG (Peroxisome proliferator-activated receptor gamma)αVβ3 (Integrin αVβ3)PPARA (Peroxisome proliferator-activated receptor alpha)FFAR4 (Free fatty acid receptor 4)
Beyond the preview
Go deeper on docosahexaenoic acid + arachidonic acid + milk fat globule membrane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on docosahexaenoic acid + arachidonic acid + milk fat globule membrane.